Chairman of the Egyptian Drug Authority Reviews Pharmaceutical Sector Development Plans Through 2030
Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Drug Authority, participated in the fifth edition of the Africa Health ExCon. During this significant event, Al-Ghamrawi spoke about the future of the pharmaceutical sector in Egypt and the ambitious plans the state aims to achieve by 2030.
The Chairman reviewed the major achievements made by the Egyptian pharmaceutical sector recently. He emphasized that Egypt is working diligently to provide high-quality medicines at affordable prices for citizens, focusing on increasing local production and reducing reliance on imports to consistently secure market needs.
Al-Ghamrawi addressed future development plans, noting that the Authority seeks to update the laws and regulations governing the pharmaceutical market. These plans aim to make Egypt a regional hub for the pharmaceutical industry in Africa and the Middle East by supporting innovation and scientific research, and developing local factories in accordance with international standards.
The Chairman also stressed the importance of cooperation with other African countries in this vital field. He explained that the Africa Health ExCon serves as an ideal platform for exchanging expertise and strengthening partnerships between Egyptian companies and companies across the continent, contributing to the improvement of healthcare standards throughout Africa.
In conclusion, this participation reflects the Egyptian state's commitment to developing its health and pharmaceutical systems sustainably. These efforts are expected to lead to an improvement in the level of medical services provided to citizens and enhance Egypt's position as a leading medical and economic power in the region in the coming years.